GENE ONLINE|News &
Opinion
Blog

Migraine
Neurolief’s Neuromodulation Device Receives Japanese Approval for At-Home Migraine Treatment
2024-01-16
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Daiichi Sankyo Partners with Lilly on a Second Migraine Drug Deal in Japan
2021-09-01
Spotlight: The Revitalization of Chronic Migraine Therapies
2020-09-02
Ubrelvy Approval, the Best New Year Gift for CGRP Migraine Victims
2020-01-09
Weekly Top 5 in China (0210-0216)
2019-02-18
Clash of three migraines medications & cost benefit for patients
2018-10-01
AJOVY™, Teva’s new migraine drug gets USFDA approval
2018-09-21
LATEST
Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal
2024-02-27
Breakthrough Study Shows Anti-IgE Antibody Safeguards Children with Multiple Food Allergies
2024-02-27
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
EVENT
Scroll to Top